3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
57
Neoplasm Metastasis
21
Carcinoma, Non-Small-Cell Lung
9
Stomach Neoplasms
8
Brain Neoplasms
8
Colorectal Neoplasms
7
Triple Negative Breast Neoplasms
4
Pancreatic Neoplasms
4
Ovarian Neoplasms
4
Endometrial Neoplasms
4
Salivary Gland Neoplasms
3
Recurrence
3
Neoplasms
3
Esophageal Neoplasms
3
Adenocarcinoma
3
Prostatic Neoplasms
2
Meningeal Carcinomatosis
2
HER2-positive Gastric Cancer
2
Colonic Neoplasms
2
Breast Cancer With Brain Metastasis
2
Advanced Solid Tumor
2
Advanced Breast Cancer
2
Adenocarcinoma Of Esophagus
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Unresectable Locally Recurrent Breast Cancer
1
Interventions
Capecitabine
42
Oxaliplatin
39
Fluorouracil
29
Leucovorin
23
Radiotherapy
22
Cetuximab
15
Bevacizumab
15
Irinotecan
13
Nivolumab
12
Magnetic Resonance Spectroscopy
11
Specimen Handling
9
Drug Therapy
9
Surgical Procedures, Operative
8
Folfox protocol
8
pembrolizumab
7
Radiotherapy, Intensity-Modulated
7
Chemoradiotherapy
7
Biopsy
7
trifluridine tipiracil drug combination
6
Radiation
6
tislelizumab
5
sintilimab
5
regorafenib
5
dehydroftorafur
5
X-Rays
5
Surveys and Questionnaires
5
Sigmoidoscopy
5
Endoscopy
5
Consolidation Chemotherapy
5
spartalizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Rectal Neoplasms
×
trastuzumab deruxtecan
×
1 year
×
Clear all
NCT07407465
2026-02-17
CHIMERA
Gruppo Oncologico del Nord-Ovest
Phase 2
Recruiting
42 enrolled